Click here to get full coverage on Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial Results - Yahoo Finance

Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial Results  Yahoo Finance

Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial Results - Yahoo Finance

Click here to get full coverage on Siren L.L.C. Sells 7,793 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Siren L.L.C. Sells 7,793 Shares of Revolution Medicines, Inc. $RVMD  MarketBeat

Siren L.L.C. Sells 7,793 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on $RVMD stock is up 14% today. Here's what we see in our data. - Quiver Quantitative

$RVMD stock is up 14% today. Here's what we see in our data.  Quiver Quantitative

$RVMD stock is up 14% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Stocks making the biggest moves midday: Delta Air Lines, Revolution Medicines, Centene and more - CNBC

Stocks making the biggest moves midday: Delta Air Lines, Revolution Medicines, Centene and more  CNBC

Stocks making the biggest moves midday: Delta Air Lines, Revolution Medicines, Centene and more - CNBC

Click here to get full coverage on Revolution Medicines: Shares Soar On Pancreatic Cancer Study Win - I'm Sold (NASDAQ:RVMD) - Seeking Alpha

Revolution Medicines: Shares Soar On Pancreatic Cancer Study Win - I'm Sold (NASDAQ:RVMD)  Seeking Alpha

Revolution Medicines: Shares Soar On Pancreatic Cancer Study Win - I'm Sold (NASDAQ:RVMD) - Seeking Alpha

Click here to get full coverage on Goldman Sachs Raises Price Target for RVMD to $73.00, Maintains Buy Rating | RVMD Stock News - GuruFocus

Goldman Sachs Raises Price Target for RVMD to $73.00, Maintains Buy Rating | RVMD Stock News  GuruFocus

Goldman Sachs Raises Price Target for RVMD to $73.00, Maintains Buy Rating | RVMD Stock News - GuruFocus

Click here to get full coverage on Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs - Yahoo Finance

Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs  Yahoo Finance

Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs - Yahoo Finance

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Shares Sold by Fred Alger Management LLC - MarketBeat

Revolution Medicines, Inc. $RVMD Shares Sold by Fred Alger Management LLC  MarketBeat

Revolution Medicines, Inc. $RVMD Shares Sold by Fred Alger Management LLC - MarketBeat

Click here to get full coverage on New Analyst Forecast: $RVMD Given $66.0 Price Target - Quiver Quantitative

New Analyst Forecast: $RVMD Given $66.0 Price Target  Quiver Quantitative

New Analyst Forecast: $RVMD Given $66.0 Price Target - Quiver Quantitative

Click here to get full coverage on Revolution Medicines (RVMD) Is Up 6.7% After Truist’s Bullish Initiation Is the Pipeline Rethink Underway? - Yahoo Finance

Revolution Medicines (RVMD) Is Up 6.7% After Truist’s Bullish Initiation Is the Pipeline Rethink Underway?  Yahoo Finance

Revolution Medicines (RVMD) Is Up 6.7% After Truist’s Bullish Initiation Is the Pipeline Rethink Underway? - Yahoo Finance

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Shares Bought by Intech Investment Management LLC - MarketBeat

Revolution Medicines, Inc. $RVMD Shares Bought by Intech Investment Management LLC  MarketBeat

Revolution Medicines, Inc. $RVMD Shares Bought by Intech Investment Management LLC - MarketBeat

Click here to get full coverage on Here’s What the Wall Street Thinks About Revolution Medicines (RVMD) - Yahoo Finance

Here’s What the Wall Street Thinks About Revolution Medicines (RVMD)  Yahoo Finance

Here’s What the Wall Street Thinks About Revolution Medicines (RVMD) - Yahoo Finance

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat

Revolution Medicines, Inc. $RVMD Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.  MarketBeat

Revolution Medicines, Inc. $RVMD Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat

Click here to get full coverage on Dynamic Technology Lab Private Ltd Acquires New Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Dynamic Technology Lab Private Ltd Acquires New Holdings in Revolution Medicines, Inc. $RVMD  MarketBeat

Dynamic Technology Lab Private Ltd Acquires New Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Revolution Medicines (RVMD): Assessing Valuation After Truist Highlights Potential of RAS-mutant Cancer Pipeline - Yahoo Finance

Revolution Medicines (RVMD): Assessing Valuation After Truist Highlights Potential of RAS-mutant Cancer Pipeline  Yahoo Finance

Revolution Medicines (RVMD): Assessing Valuation After Truist Highlights Potential of RAS-mutant Cancer Pipeline - Yahoo Finance

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Given New $66.00 Price Target at Needham & Company LLC - MarketBeat

Revolution Medicines (NASDAQ:RVMD) Given New $66.00 Price Target at Needham & Company LLC  MarketBeat

Revolution Medicines (NASDAQ:RVMD) Given New $66.00 Price Target at Needham & Company LLC - MarketBeat

Click here to get full coverage on Oppenheimer Reaffirms Outperform on Revolution Medicines (RVMD) Amid RAS Therapy Progress - Yahoo Finance

Oppenheimer Reaffirms Outperform on Revolution Medicines (RVMD) Amid RAS Therapy Progress  Yahoo Finance

Oppenheimer Reaffirms Outperform on Revolution Medicines (RVMD) Amid RAS Therapy Progress - Yahoo Finance

Click here to get full coverage on Wedbush Research Analysts Lower Earnings Estimates for RVMD - MarketBeat

Wedbush Research Analysts Lower Earnings Estimates for RVMD  MarketBeat

Wedbush Research Analysts Lower Earnings Estimates for RVMD - MarketBeat

Click here to get full coverage on Raymond James Financial Begins Coverage on Revolution Medicines (NASDAQ:RVMD) - MarketBeat

Raymond James Financial Begins Coverage on Revolution Medicines (NASDAQ:RVMD)  MarketBeat

Raymond James Financial Begins Coverage on Revolution Medicines (NASDAQ:RVMD) - MarketBeat

Click here to get full coverage on Wells Fargo & Company Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - MarketBeat

Wells Fargo & Company Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price  MarketBeat

Wells Fargo & Company Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - MarketBeat

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $77.00 - MarketBeat

Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $77.00  MarketBeat

Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $77.00 - MarketBeat

Click here to get full coverage on Brokerages Set Revolution Medicines, Inc. (NASDAQ:RVMD) PT at $72.00 - MarketBeat

Brokerages Set Revolution Medicines, Inc. (NASDAQ:RVMD) PT at $72.00  MarketBeat

Brokerages Set Revolution Medicines, Inc. (NASDAQ:RVMD) PT at $72.00 - MarketBeat

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Shares Gap Up Following Analyst Upgrade - MarketBeat

Revolution Medicines (NASDAQ:RVMD) Shares Gap Up Following Analyst Upgrade  MarketBeat

Revolution Medicines (NASDAQ:RVMD) Shares Gap Up Following Analyst Upgrade - MarketBeat

Click here to get full coverage on Revolution Medicines (RVMD): Assessing Valuation After New Analyst Coverage and FDA Breakthrough Designations - simplywall.st

Revolution Medicines (RVMD): Assessing Valuation After New Analyst Coverage and FDA Breakthrough Designations  simplywall.st

Revolution Medicines (RVMD): Assessing Valuation After New Analyst Coverage and FDA Breakthrough Designations - simplywall.st

Click here to get full coverage on Did Truist’s Coverage of RAS Pipeline Just Shift Revolution Medicines’ (RVMD) Investment Narrative? - simplywall.st

Did Truist’s Coverage of RAS Pipeline Just Shift Revolution Medicines’ (RVMD) Investment Narrative?  simplywall.st

Did Truist’s Coverage of RAS Pipeline Just Shift Revolution Medicines’ (RVMD) Investment Narrative? - simplywall.st

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Position Reduced by Adage Capital Partners GP L.L.C. - MarketBeat

Revolution Medicines, Inc. $RVMD Position Reduced by Adage Capital Partners GP L.L.C.  MarketBeat

Revolution Medicines, Inc. $RVMD Position Reduced by Adage Capital Partners GP L.L.C. - MarketBeat

Click here to get full coverage on Trexquant Investment LP Acquires New Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Trexquant Investment LP Acquires New Position in Revolution Medicines, Inc. $RVMD  MarketBeat

Trexquant Investment LP Acquires New Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD  MarketBeat

Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Revolution Medicines (RVMD): Exploring Valuation After Truist Coverage Highlights Pipeline Potential - simplywall.st

Revolution Medicines (RVMD): Exploring Valuation After Truist Coverage Highlights Pipeline Potential  simplywall.st

Revolution Medicines (RVMD): Exploring Valuation After Truist Coverage Highlights Pipeline Potential - simplywall.st

Click here to get full coverage on Day Trade: What is RVMD s 5 year growth outlook - 2025 Momentum Check & Community Verified Watchlist Alerts - خودرو بانک

Day Trade: What is RVMD s 5 year growth outlook - 2025 Momentum Check & Community Verified Watchlist Alerts  خودرو بانک

Day Trade: What is RVMD s 5 year growth outlook - 2025 Momentum Check & Community Verified Watchlist Alerts - خودرو بانک

Click here to get full coverage on Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade - Yahoo Finance

Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade  Yahoo Finance

Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade - Yahoo Finance

Click here to get full coverage on The Goldman Sachs Group Forecasts Strong Price Appreciation for Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat

The Goldman Sachs Group Forecasts Strong Price Appreciation for Revolution Medicines (NASDAQ:RVMD) Stock  MarketBeat

The Goldman Sachs Group Forecasts Strong Price Appreciation for Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat

Click here to get full coverage on Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug - Benzinga

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug  Benzinga

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug - Benzinga

Click here to get full coverage on Risks Report: What are analysts price targets for RVMD - 2025 Key Lessons & Weekly Watchlist for Consistent Profits - خودرو بانک

Risks Report: What are analysts price targets for RVMD - 2025 Key Lessons & Weekly Watchlist for Consistent Profits  خودرو بانک

Risks Report: What are analysts price targets for RVMD - 2025 Key Lessons & Weekly Watchlist for Consistent Profits - خودرو بانک

Click here to get full coverage on Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $RVMD Given $56.0 Price Target | RVMD Stock News - Quiver Quantitative

New Analyst Forecast: $RVMD Given $56.0 Price Target | RVMD Stock News  Quiver Quantitative

New Analyst Forecast: $RVMD Given $56.0 Price Target | RVMD Stock News - Quiver Quantitative

Click here to get full coverage on Interesting RVMD Put And Call Options For April 2026 - Nasdaq

Interesting RVMD Put And Call Options For April 2026  Nasdaq

Interesting RVMD Put And Call Options For April 2026 - Nasdaq

Click here to get full coverage on Exclusive BAC Article: Revolution Medicines; Positive Phase 1 Data 2nd-Line mPDAC RAS-Mutant Patients, Phase 3 Topline Data 2026, Expansions Into Adjuvant Setting And Catalysts (NASDAQ:RVMD) - Seeking Alpha

Exclusive BAC Article: Revolution Medicines; Positive Phase 1 Data 2nd-Line mPDAC RAS-Mutant Patients, Phase 3 Topline Data 2026, Expansions Into Adjuvant Setting And Catalysts (NASDAQ:RVMD)  Seeking Alpha

Exclusive BAC Article: Revolution Medicines; Positive Phase 1 Data 2nd-Line mPDAC RAS-Mutant Patients, Phase 3 Topline Data 2026, Expansions Into Adjuvant Setting And Catalysts (NASDAQ:RVMD) - Seeking Alpha

Click here to get full coverage on Insider Sale: Chief Financial Officer of $RVMD Sells 4,762 Shares - Quiver Quantitative

Insider Sale: Chief Financial Officer of $RVMD Sells 4,762 Shares  Quiver Quantitative

Insider Sale: Chief Financial Officer of $RVMD Sells 4,762 Shares - Quiver Quantitative

Click here to get full coverage on Earnings Risk: Is RVMD stock a good dividend stock - July 2025 Short Interest & High Yield Stock Recommendations - خودرو بانک

Earnings Risk: Is RVMD stock a good dividend stock - July 2025 Short Interest & High Yield Stock Recommendations  خودرو بانک

Earnings Risk: Is RVMD stock a good dividend stock - July 2025 Short Interest & High Yield Stock Recommendations - خودرو بانک

Click here to get full coverage on Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on What To Expect From Revolution Medicines Inc (RVMD) Q2 2025 Earnings - Yahoo Finance

What To Expect From Revolution Medicines Inc (RVMD) Q2 2025 Earnings  Yahoo Finance

What To Expect From Revolution Medicines Inc (RVMD) Q2 2025 Earnings - Yahoo Finance

Click here to get full coverage on Revolution Medicines’ Surging Potential: What’s Happening? - StocksToTrade

Revolution Medicines’ Surging Potential: What’s Happening?  StocksToTrade

Revolution Medicines’ Surging Potential: What’s Happening? - StocksToTrade

Click here to get full coverage on Granahan Investment Management LLC Acquires 7,322 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Granahan Investment Management LLC Acquires 7,322 Shares of Revolution Medicines, Inc. $RVMD  MarketBeat

Granahan Investment Management LLC Acquires 7,322 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Revolution Medicines Lands Massive $2B Deal to Advance Revolutionary Cancer Treatment Program - Stock Titan

Revolution Medicines Lands Massive $2B Deal to Advance Revolutionary Cancer Treatment Program  Stock Titan

Revolution Medicines Lands Massive $2B Deal to Advance Revolutionary Cancer Treatment Program - Stock Titan

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Truist Financial - MarketBeat

Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Truist Financial  MarketBeat

Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Truist Financial - MarketBeat

Click here to get full coverage on Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts  Yahoo Finance

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Shares Bought by Magnetar Financial LLC - MarketBeat

Revolution Medicines, Inc. $RVMD Shares Bought by Magnetar Financial LLC  MarketBeat

Revolution Medicines, Inc. $RVMD Shares Bought by Magnetar Financial LLC - MarketBeat

Click here to get full coverage on Revolution Medicines, Inc. $RVMD Position Reduced by Walleye Capital LLC - MarketBeat

Revolution Medicines, Inc. $RVMD Position Reduced by Walleye Capital LLC  MarketBeat

Revolution Medicines, Inc. $RVMD Position Reduced by Walleye Capital LLC - MarketBeat

Click here to get full coverage on TD Cowen Maintains Revolution Medicines(RVMD.US) With Buy Rating - 富途牛牛

TD Cowen Maintains Revolution Medicines(RVMD.US) With Buy Rating  富途牛牛

TD Cowen Maintains Revolution Medicines(RVMD.US) With Buy Rating - 富途牛牛

Click here to get full coverage on Revolution Medicines (NASDAQ:RVMD) Stock Price Up 5.2% - Still a Buy? - MarketBeat

Revolution Medicines (NASDAQ:RVMD) Stock Price Up 5.2% - Still a Buy?  MarketBeat

Revolution Medicines (NASDAQ:RVMD) Stock Price Up 5.2% - Still a Buy? - MarketBeat

Click here to get full coverage on Revolution Medicines: Positioning Itself To Capture One Of The Largest Cancer Targets In History - Seeking Alpha

Revolution Medicines: Positioning Itself To Capture One Of The Largest Cancer Targets In History  Seeking Alpha

Revolution Medicines: Positioning Itself To Capture One Of The Largest Cancer Targets In History - Seeking Alpha

Click here to get full coverage on CW Advisors LLC Takes $654,000 Position in Revolution Medicines, Inc. $RVMD - MarketBeat

CW Advisors LLC Takes $654,000 Position in Revolution Medicines, Inc. $RVMD  MarketBeat

CW Advisors LLC Takes $654,000 Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $78 - 富途牛牛

BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $78  富途牛牛

BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $78 - 富途牛牛

Click here to get full coverage on Clinical Oncology Pioneer Revolution Medicines Sets Q2 Earnings Release: Key RAS Cancer Updates Expected - Stock Titan

Clinical Oncology Pioneer Revolution Medicines Sets Q2 Earnings Release: Key RAS Cancer Updates Expected  Stock Titan

Clinical Oncology Pioneer Revolution Medicines Sets Q2 Earnings Release: Key RAS Cancer Updates Expected - Stock Titan

Click here to get full coverage on Ameriprise Financial Inc. Reduces Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Ameriprise Financial Inc. Reduces Position in Revolution Medicines, Inc. $RVMD  MarketBeat

Ameriprise Financial Inc. Reduces Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Tema Etfs LLC Has $3.34 Million Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Tema Etfs LLC Has $3.34 Million Holdings in Revolution Medicines, Inc. $RVMD  MarketBeat

Tema Etfs LLC Has $3.34 Million Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Click here to get full coverage on Published on: 2025-09-15 13:41:00 - خودرو بانک

Published on: 2025-09-15 13:41:00  خودرو بانک

Published on: 2025-09-15 13:41:00 - خودرو بانک

Click here to get full coverage on A novel fault diagnosis method for gearbox based on RVMD and TELM with composite chaotic grey wolf optimizer - Nature

A novel fault diagnosis method for gearbox based on RVMD and TELM with composite chaotic grey wolf optimizer  Nature

A novel fault diagnosis method for gearbox based on RVMD and TELM with composite chaotic grey wolf optimizer - Nature

Click here to get full coverage on Market Catalysts: Is RVMD likely to announce a buyback - July 2025 Levels & Fast Gain Swing Alerts - خودرو بانک

Market Catalysts: Is RVMD likely to announce a buyback - July 2025 Levels & Fast Gain Swing Alerts  خودرو بانک

Market Catalysts: Is RVMD likely to announce a buyback - July 2025 Levels & Fast Gain Swing Alerts - خودرو بانک

Click here to get full coverage on New Analyst Forecast: $RVMD Given 'Overweight' Rating - Quiver Quantitative

New Analyst Forecast: $RVMD Given 'Overweight' Rating  Quiver Quantitative

New Analyst Forecast: $RVMD Given 'Overweight' Rating - Quiver Quantitative

Click here to get full coverage on Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire

Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress  GlobeNewswire

Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire

Click here to get full coverage on Revolution Medicines Secures FDA Breakthrough Status for Novel KRAS Lung Cancer Treatment - Stock Titan

Revolution Medicines Secures FDA Breakthrough Status for Novel KRAS Lung Cancer Treatment  Stock Titan

Revolution Medicines Secures FDA Breakthrough Status for Novel KRAS Lung Cancer Treatment - Stock Titan

Click here to get full coverage on Performance Recap: Is RVMD backed by strong institutional buying - July 2025 Action & Verified Short-Term Plans - خودرو بانک

Performance Recap: Is RVMD backed by strong institutional buying - July 2025 Action & Verified Short-Term Plans  خودرو بانک

Performance Recap: Is RVMD backed by strong institutional buying - July 2025 Action & Verified Short-Term Plans - خودرو بانک

Click here to get full coverage on Revolution Medicines, Inc. (RVMD) Q2 FY2025 earnings call transcript - Yahoo Finance

Revolution Medicines, Inc. (RVMD) Q2 FY2025 earnings call transcript  Yahoo Finance

Revolution Medicines, Inc. (RVMD) Q2 FY2025 earnings call transcript - Yahoo Finance

Click here to get full coverage on Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025 - GlobeNewswire

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025  GlobeNewswire

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025 - GlobeNewswire

Click here to get full coverage on Revolution Medicines Stock Skyrockets: What’s Next? - timothysykes.com

Revolution Medicines Stock Skyrockets: What’s Next?  timothysykes.com

Revolution Medicines Inc (RVMD)

Price Chart

Key Statistics

Technicals

About RVMD

Latest News

Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial Results - Yahoo Finance

Siren L.L.C. Sells 7,793 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

$RVMD stock is up 14% today. Here's what we see in our data. - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers